期刊文献+

替吉奥联合顺铂治疗晚期胃癌的近期疗效观察 被引量:5

Short-term clinal investigation of combination chemotherapy with TS-1 and cisplatin on advanced gastric cancer
原文传递
导出
摘要 目的探讨替吉奥联合顺铂治疗晚期胃癌的有效性和安全性。方法采用非盲法随机对照试验。治疗组27例,替吉奥胶囊根据体表面积给药,<1.25m2,40mg,bid;1.25~1.50m2,50mg,bid;>1.50m2,60mg,bid,早晚餐后口服,d1~d14。顺铂:75mg/m2,d1~d3,21d为一疗程。对照组26例,5-Fu 600mg.m-2.d-1以微量泵进行持续静脉滴注,d1~d5;顺铂20mg.m-2.d-1,静脉滴注,d1~d5。28d为一疗程。每完成2个周期复查评价疗效和生活质量状况,观察并记录不良反应。结果治疗组有效率为59.3%,对照组为19.2%,两组间比较差异有统计学意义(P=0.005)。临床获益率比较,治疗组为88.9%,对照组为53.8%,两组间比较差异有统计学意义(P=0.006)。治疗前后治疗组与对照组患者KPS评分改善情况差异有统计学意义(P=0.035),治疗后对照组KPS评分降低较治疗组有显著性差异(P=0.006)。两组患者主要不良反应为消化道毒性、血液学毒性和肝脏毒性,两组间比较差异无统计学意义(P>0.05)。结论替吉奥联合顺铂治疗晚期胃癌安全、有效。 Objective To evaluate the effectiveness and safety of combination chemotherapy with TS-1 and eisplatin on advanced gastric cancer. Methods We conducted a non-blinded, randomized, con- trolled trial, 53 patients with advanced gastric cancer were randomly assigned to two groups. The treatment group(n =27) administered with TS-1 capsule( doses based on patients'body surface area: 〈 1. 25m2, 40mg,bid; 1. 25 - 1. 50m2,50mg, bid; 〉 1. 50m2,60mg, bid, from day 1 to 14) plus eisplatin (75mg/m2from day 1 through day 3 ) every 21 days. The control group (n = 26 ) administered with 5-Fu 600mg/( m2 · d) intravenous drip from day 1 to day 5 by micro-pump infusion continuously and cisplatin 20rag/( m2 · d) intravenous drip on day 1 to day 5 every 28 days. The response rate,life quality and adverse reaction were evaluated after every 2 cycles. Results In the treatment group the effective rate(59. 3% ) , clinical beneficial rate ( 88. 9% ) and improvement of life quality (44.4%) were significantly higher than those of the control group respectly ( P 〈 0. 05 ). The decrease of life quality were found in 46. 2% of the control group and 11.1% of the treatment group( P 〈 0. 05 ). The main adverse events were alimentary canal toxicity,hematologic system and hepatotoxieity. There was no significant difference between the two groups (P 〉 0. 05). Conclusions TS-1 capsule combined with cisplatin is safe and effective in the treatment of advanced gastric cancer.
出处 《中国肿瘤临床与康复》 2012年第5期425-427,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃肿瘤 替吉奥 顺铂 药物疗法 Gastric neoplasms TS-1 Cisplatin Drug therapy
  • 相关文献

参考文献4

  • 1Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Insitute of Canada[ J ]. J Natl Cancer Inst, 2000, 92:205-216.
  • 2Alberts SR,Cervantes A,Vande Velde C J,et al. Gastric cancer: epidemiology, pathology and treatment [ J ]. Ann Oncol, 2003, 14:S31.
  • 3Malet Martino M, Martino R. Clinical studies of three oral pro- drugs of 5-fluorouracil ( capecitabine, UFT, S-1 ) : a review [J]. Oncologist, 2002, 7:288-323.
  • 4Tanaka F, Fukuse T, Wada H, et al. The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents[ J] . Curt Pharm Biotechnol, 2000, 1:137-164.

同被引文献27

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部